Lykon’s EUR 6.4 Million Pre-Series A Funding Round

Osborne Clarke advised MA Ventures on the deal.

HealthTech startup Lykon has raised EUR 6.4 million in its Pre-Series A funding round. MA Ventures used the Redstone platform, a fast growing VC service provider from Berlin. The new funds will be used to continue to improve the customer journey and develop the technology. A Series A financing round is envisaged for the end of 2021/early 2022.

Leading the round were MA Ventures, the venture capital fund of the Migros Aare cooperative, and RI Digital Ventures, the investment company of Ippen Digital media group. Also joining this round were existing investors, including Patrick Schmidt (Co-CEO Global Fashion Group).

Lykon is Germany’s market leader for personalized nutrition concepts based on certified blood and DNA tests. 

The Osborne Clarke team that advised MA Ventures was led by Maximilian Vocke (Picture – VC / Corporate) and consisted of Dana Alpar (VC / Corporate), Dr. Robert Rentsch and Kamissa Kruse (both Employment), Dr. Tim Reinhard and Konstantin Sitte (both Healthcare), Benjamin Schaum, Dr. Christian Woger and Adrian Schneider (IP/IT/Data) and Dr. Jens Wrede (Tax).

Involved fees earner: Dana Alpar – Osborne Clarke; Christian Woger – Osborne Clarke; Kamissa Kruse – Osborne Clarke; Tim Reinhard – Osborne Clarke; Robert Rentsch – Osborne Clarke; Benjamin Schaum – Osborne Clarke; Adrian Schneider – Osborne Clarke; Konstantin Sitte – Osborne Clarke; Maximilian Vocke – Osborne Clarke; Jens Wrede – Osborne Clarke;

Law Firms: Osborne Clarke;

Clients: MA Ventures;

Author: Federica Tiefenthaler